Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Royal Sense Ltd announces the official launch of latest products in Pharmaceutical Category

Posted On: 2024-08-28 19:54:44 (Time Zone: IST)


Royal Sense Ltd has announced the launch of its new products Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale from August 28, 2024.

OPENTOP 40

Details: Pantoprazole 40 mg reduces stomach acid, treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor.

Description

Pantoprazole 40 mg is a medication primarily used to treat conditions related to excessive stomach acid production, such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers. It belongs to a class of drugs known as proton pump inhibitors (PPIs), which work by blocking the proton pumps in the stomach lining that produce acid. This reduction in stomach acid helps alleviate symptoms like heartburn and promotes the healing of the esophagus and stomach lining. Pantoprazole is typically taken orally, usually once daily, and can be prescribed for both short-term and long-term use. Common side effects may include headaches, diarrhoea, and nausea. It is important to follow the dosage prescribed by a healthcare provider to minimise potential side effects.

OPENTOP D

Details: Pantoprazole 40 mg reduces stomach acid treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor, while domperidone 10 mg improves gastrointestinal motility and reduces nausea and vomiting.

Description

Pantoprazole 40 mg and domperidone 10 mg are often used together to address gastrointestinal issues. Pantoprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, treating conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome. By reducing acid, it helps heal the esophagus and stomach lining and alleviates symptoms such as heartburn. Domperidone is a prokinetic agent that enhances gastrointestinal motility and helps relieve nausea and vomiting by facilitating gastric emptying and improving coordination of stomach contractions. This combination can be particularly effective for managing symptoms associated with delayed gastric emptying and acid-related disorders. Common side effects include headaches and gastrointestinal disturbances, so it's essential to use these medications under medical supervision.

CEFIX 200

Details: Cefixime 200 mg is an oral antibiotic that treats bacterial infections like pneumonia, ear infections, and gonorrhea.

Description

Cefixime 200 mg is a broad-spectrum oral antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which work by inhibiting bacterial cell wall synthesis, thereby killing bacteria. Cefixime is effective against infections such as pneumonia, bronchitis, ear infections, throat infections, and urinary tract infections. It is also used for treating gonorrhea. The medication is typically taken once or twice daily, depending on the infection and the patient's condition. Common side effects include diarrhea, nausea, and abdominal pain. It's important to complete the full course of treatment as prescribed, even if symptoms improve, to prevent antibiotic resistance and ensure the infection is fully eradicated. Always follow a healthcare provider's instructions when using cefixime.

OPENTOP DSR

Details: Pantoprazole 40 mg reduces stomach acid treating GERD and ulcers by inhibiting proton pumps. It's a proton pump inhibitor, while domperidone 30 mg with delayed release property improves gastrointestinal motility and reduces nausea and vomiting for extended duration.

Description

Pantoprazole 40 mg is a combination medication that includes pantoprazole and domperidone. Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, helping to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Domperidone, a prokinetic agent, enhances gastrointestinal motility, reducing symptoms like nausea and vomiting. Together, they address both acid-related issues and digestive motility problems. Pantop DSR is commonly prescribed for patients experiencing symptoms related to excessive stomach acid and impaired digestion. It is usually taken orally, once daily, before meals. Common side effects may include headache, dry mouth, and gastrointestinal disturbances. It is essential to follow the prescribed dosage and consult a healthcare provider for proper usage.

OPENTOP L

Details: Opentop L combines pantoprazole 40mg and levosulpiride 75mg, reducing stomach acid and improving gastrointestinal motility, treating GERD and related symptoms.

Description:

Opentop L is a combination medication that includes pantoprazole and levosulpiride. Pantoprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, effectively treating conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and ZollingerEllison syndrome. It helps in alleviating heartburn and promoting healing of the esophagus and stomach lining. Levosulpiride, a prokinetic agent, enhances gastrointestinal motility, which helps relieve symptoms such as nausea, vomiting, and abdominal discomfort by improving the movement of the digestive tract. This combination addresses both excessive acid production and motility issues. Pantop L is typically prescribed for managing symptoms associated with acid reflux and digestive disturbances. Common side effects may include headache, gastrointestinal disturbances, and dizziness. Always follow the prescribed dosage and consult a healthcare provider for proper use.

Shares of Royal Sense Limited was last trading in BSE at Rs. 145.00 as compared to the previous close of Rs. 145.95. The total number of shares traded during the day was 6000 in over 3 trades.

The stock hit an intraday high of Rs. 145.00 and intraday low of 145.00. The net turnover during the day was Rs. 870000.00.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Padma Shri Award-winning Scientist and Father of Akash Missile, Dr. Prahlada Ramarao, to Advise CMD of Brightcom Group

Torrent Group's Green Hydrogen Plant in Gorakhpur Inaugurated by Shri Yogi Adityanath, Hon'ble Chief Minister of Uttar Pradesh

Alan Scott LearniX Pvt Ltd launches advanced AI-pzowered Education Platform KrishGuru

NITCO Q1 Revenue Surges 114% on Alibaug Deal, Tiles Growth

KEC International wins New Orders of Rs. 1,402 crores

Hindustan Oil Exploration Company Ltd update on Block B-80

Electronics Mart India Ltd opens new Bajaj Electronics store at Srikakulam

Shanmuga Hospital Ltd commissions advanced PH Impedance and Manometry System

Baazar Style Retail Ltd opens new store at Bihpuria

Shree Ajit Pulp and Paper Ltd shuts down plant temporarily

Century Ports Ltd commences commercial operations at its rejuvenated Khidderpore Docks

Meta Infotech Ltd receives order worth Rs. 52.91 lakhs

OnMobile reports strong Q1 FY26 with Double-Digit Growth in Gaming Subscribers and Revenue

Signatureglobal Business Park Ltd acquires 33.47 acres land

EaseMyTrip Board approves 3 acquisitions to Strengthen Strategic Presence

PVR INOX opens 10-screen Megaplex at the Sky City Mall in Borivali East, Mumbai

Hindustan Copper PBT increases by more than 16%

Globe Civil Projects Ltd receives LOA for order worth Rs. 222.19 crores

Weaver Services completes acquisition of Capital India Home Loans after regulatory approval

Affordable Robotic and Automation Limited Reports Year-on-Year Improvement in Q1 FY2026 Performance

Calcom Vision Reports Q1 FY26 PAT at Rs 0.69 Crore, up 138.72% YoY; Revenue from Operations Rises 146.82% YoY to Rs 45.07crore

Nazara Doubles Q1FY26 Revenues to ?498.8 Cr, EBITDA Up 90% to ?47.4 Cr and PAT Increases by 118% to ?51.3 Cr

Arisinfra Solutions achieves record sales for Bodhii Tree Villa Plot Development Near NH-75

HCLTech commemorates the 49th anniversary of HCL Group by planting 49,000 saplings across India

SBI Life launches 'SBI Life - Smart Shield Plus', a future-ready term insurance plan designed for consumer's evolving insurance needs

Neopolitan Pizza and Foods Limited Expands with a New Company-Owned Location at 'THE C Wing Mall,' Una - Gir Gadhda

KIL reports Q1FY 2026 results, consolidated net profit at INR 95 crore

FSN E-Commerce Ventures Ltd to acquire balance 40% stake in Nudge Wellness Pvt Ltd

Piccadily Agro Industries Ld announces Q1 FY2026 results

P N Gadgil Jewellers Limited opens new store at Nashik

Cohance Lifesciences announces ?230 mn investment and progress on cGMP Oligonucleotide Facility at Hyderabad, India

Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags

KVB inaugurates a new branch in Trichy

Transrail secures fresh orders worth ?701 crore

Firstsource named a 'Star Performer' and a 'Major Contender' in Everest Group's Financial Crime and Compliance (FCC) Operations Services PEAK Matrix® Assessment 2025

Kovilpatti Lakshmi Roller Flour Mills Ltd approves capex in Foods Division

PTC Industries and Kineco Aerospace & Defence announce strategic MoU to Collaborate on Value-Added Aerospace Components & Structures

GP Petroleums Ltd reports Q1 FY 2025-26 Results with PBT of ?8.57 Crores on Revenue of ?168 Crores

MRF announces Q1 FY2025-26 results

MIC Electronics Limited receives BIS certificates

Nibe Ltd receives orders worth Rs. 26.67 crores

RBL Bank Partners with CAMS to Provide Merchant Acquiring Settlement service

Hindustan Zinc becomes the First Indian Company to Join the International Council on Mining and Metals

Neogen Chemicals raises INR 200 crore via NCDs

Mangal Credit and Fincorp Ltd to open new branch at Nathdwara

RMC Switchgears Limited reports Q1 FY2025-26 PBT of ? 12.44 Crores, Maintains Strong Growth Momentum

DroneAcharya Aerial Innovations Ltd secures INR 99.67 Lakh work order from Indian Army for Drone Supply and Advanced Drone Lab Setup

izmo Ltd unveils The Automotive AI Factory

Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio, Princeton, NJ, U.S. to Accelerate ADC Innovation

Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020